HUGA Place Orders for 6 Aixtron MOCVD Reactors

AIXTRON AG announced today that in the second quarter 2009 HUGA Co., Ltd placed an order for six AIX 2800G4 HT MOCVD reactors in the 42x2 inch configuration. They will be delivered in the fourth quarter 2009 and installed at the company's state of the art production facility in the Taichung Science Park, Taiwan.

Sybil Yang, CEO, comments, "We already have thirteen AIXTRON AIX 2800G4 HT mass production MOCVD systems in operation for the high volume manufacture of LED epiwafers. The No. 2 LED chip maker in Taiwan, HUGA will place more orders for MOCVD systems in 2010 to increase the capacity to surpass competitors. The next phase of expansion in our business involves the strongly growing high-brightness backlighting LED product market and it is necessary to add further manufacturing capacity. Having served us so well, we looked to AIXTRON once again - we know we can rely on the company to provide us with high performance tools and excellent back-up service. This service has given us all we need in process technology as well as high manufacturing efficiencies and productivity."

HUGA was founded in 1998 first commercializing its GaN optoelectronics product in 2000. The company has a manufacturing facility dedicated to making LED chips using MOCVD through to chip fabrication. Examples of its recent R & D achievements include a novel epi-structure and electrode design to increase the light efficiency of middle-size LEDs for LED TV and of high power LEDs for lighting applications. It also plans to enter more diversified application markets for lighting and automotive in the near future.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.